New modelling conducted for the World Health Organisation has shown that across Europe, an estimated 17 million people experienced long COVID in the first two years of the pandemic.
The research, carried out by the Institute for Health Metrics and Evaluation at the University of Washington’s School of Medicine in the United States, also found that in severe cases, where hospital admission was necessary, one in three females and one in five males were likely to develop long COVID.
Hans Kluge, WHO regional director for Europe, said at a WHO Regional Committee for Europe meeting in Tel Aviv, Israel:
“We need all countries in the WHO European region to recognise that long COVID is a serious problem, with serious consequences, and requires a serious response to stop the lives of those affected from getting any worse—and not just on a physical health level.
“We are hearing stories of so many individual tragedies, of people in financial crisis, facing relationship problems, losing their jobs, and falling into depression. Many health workers who risked their lives on the front lines of the pandemic now have this chronic and debilitating condition as a result of infection acquired in the workplace.
“They, and millions of others, need our support. The consequences of long COVID are clearly severe and multifaceted.”
What is long COVID?
Long COVID is classified as symptoms persisting for more than four weeks after the first suspected coronavirus (COVID-19) infection that are not attributed to anything else. While many people who contract COVID fight off the virus and regain their full health again, many do not.
In the latest research, long COVID symptoms were grouped around three symptom clusters: respiratory, cognitive, and fatigue or mood swings. The data showed that females were twice as likely as males to experience long COVID, classified as symptoms lasting at least three months.
Common symptoms include:
- Extreme fatigue
- Brain fog
- Depression & anxiety
- Shortness of breath
- Muscle aches
Numerous studies over the past couple of years have highlighted just how damaging long COVID can be. 64% of people with long COVID symptoms reported that it adversely affected their day-to-day activities whilst 19% reported that their ability to undertake their day-to-day activities had been “limited a lot.”
But help is available…
IV infusions for long COVID
Our long COVID infusion program is designed to alleviate many of the negative symptoms associated with long COVID. We build your program around the results of your initial blood test. We screen the activity, efficiency and health of your mitochondria, the powerhouses of our cells, which gives our medical team clues about the causes of your Long COVID symptoms. Then, through IV infusions we help replenish your NAD+ levels after COVID-19, repair cellular damage and help your body develop a better immune response to a viral attack.
- Reduced long covid symptoms
- Increased energy and strength
- Fatigue reduction
- Improved mental and physical performance
Don’t suffer in silence. Find out more about our IV infusions for long COVID.